PT-141 (Bremelanotide / Vyleesi): An FDA-approved, as-needed injection that acts on brain melanocortin pathways to raise sexual desire in certain premenopausal women, with real but modest effect sizes.
Melanocortin receptor agonist · FDA-approved (Vyleesi, 2019)
Read the full breakdown →Latest in the report
Melanocortin receptor agonist · FDA-approved (Vyleesi, 2019)
PT-141 (Bremelanotide / Vyleesi)
An FDA-approved, as-needed injection that acts on brain melanocortin pathways to raise sexual desire in certain premenopausal women, with real but modest effect sizes.
Read more →Endogenous neuropeptide hormone · FDA-approved (IV/IM obstetrics); intranasal investigational
Oxytocin
A natural hormone that is FDA-approved for labor and proven in milk let-down, but whose intranasal use for mood, bonding, or libido remains investigational and mixed.
Read more →60-second quiz
Which compound fits your goal?
Four quick questions, then a plain-English, sourced match — no fluff.
Copper-binding signal peptide · Cosmetic ingredient (topical); not an approved drug
GHK-Cu (Copper Tripeptide)
A naturally occurring copper-binding peptide used in topical skincare, with small human trials suggesting improvements in skin firmness and fine lines.
Read more →GHRH analog (growth-hormone-releasing) · FDA-approved (Egrifta, HIV lipodystrophy)
Tesamorelin (Egrifta)
An FDA-approved growth-hormone-releasing peptide proven to cut visceral belly fat in HIV-associated lipodystrophy, but not approved for general weight loss or anti-aging.
Read more →Featured talks & podcasts
Independent third-party episodes worth your time on this topic. We don't produce or sponsor them.
▶
🎙 Hit Play Not PauseWhen BRCA1 Means Young, Surgical Menopause: Relief, Grief, and Starting Over with Sara Aranda (Episode 284)
Listen · Jul 29, 2026 →
▶
🎙 Huberman LabYour Top Health Questions Answered
Listen · Jul 27, 2026 →
▶
🎙 Huberman LabEssentials: Tools for Hormone Optimization in Males | Dr. Kyle Gillett
Listen · Jul 2, 2026 →▶
🎙 Huberman LabEating for Better Sleep & Foods that Improve Metabolic Health | Dr. Marie-Pierre St-Onge
Listen · Jun 8, 2026 →▶
🎙 Huberman LabPeptides: The Science, Uses & Safety | Dr. Abud Bakri
Listen · Jun 1, 2026 →
▶
🎙 Huberman LabEssentials: Understanding & Controlling Aggression
Listen · May 14, 2026 →Quick reference
Peptides women research for wellness & vitality
Peptides are naturally occurring chains of amino acids — signals that help promote, not replace, the body's own functions. Here's an honest map of which peptides researchers study for which goals, and where the science actually stands. We're a source of truth, not a seller.
Here's how common women's-health goals map to the peptides researchers study, with an honest read on each. Educational context; anything hormonal belongs with a qualified clinician.
| Goal | Peptide(s) studied | What the research shows |
|---|---|---|
| Libido / desire | PT-141 (Bremelanotide / Vyleesi) | FDA-approved for low sexual desire in premenopausal women — a melanocortin peptide. |
| Skin quality | GHK-Cu | A copper tripeptide with strong skin-renewal and tissue-repair research. |
| Stress / mood | Selank | A peptide studied for calm, anxiety and mood support. |
| Bonding / wellbeing | Oxytocin | A natural bonding hormone; intranasal forms are an active research area. |
| Sleep | Epitalon, DSIP | Studied for sleep quality and circadian rhythm. |
| Skin tone / tanning | Melanotan II (MT-2) | A melanocortin peptide studied for skin pigmentation and tanning, in the same melanocortin family as PT-141. A research compound — like any, best used thoughtfully and with guidance. |
Educational reference — what these peptides are studied for and where the science honestly stands. Not medical advice or a substitute for a qualified clinician's guidance. We're a source of truth, not a seller.
The deep dive
Women's health: the evidence the research mostly skipped
Women were underrepresented in clinical research for decades, so the honest starting point is that the data is thinner and more life-stage-dependent than the confident headlines suggest. Here's how to read it across hormones, libido, skin, and metabolism.
Life stage changes everything
A compound's effect can differ across the menstrual cycle, pregnancy, perimenopause, and postmenopause because the hormonal backdrop is different in each. Evidence generated in one stage doesn't automatically transfer to another — a nuance most marketing ignores entirely.
What's actually approved
A few compounds discussed here are FDA-approved for specific female indications (for example, a melanocortin agonist for certain causes of low sexual desire). Many others are investigational, cosmetic-only, or studied mostly in men and extrapolated. We mark which is which, because extrapolating male data to women is exactly the error the field is trying to correct.
Hormones, skin, and signal peptides
From estrogen's role across tissues to copper-binding peptides used topically in skincare, we separate what has human evidence from what rests on mechanism or small studies — and we grade accordingly, without pretending a cosmetic ingredient is a systemic therapy.
Educational summary of published, third-party research and handling literature. Not medical advice; not a claim of efficacy or safety for any use. We sell nothing and recommend no seller.
Stay current on the research
New, plain-language summaries as the literature develops. Educational only — no products, nothing for sale.